Search

Displaying results 4181 - 4190 of 10000 in total
  1. Drug

    Trolnitrate

    go.drugbank.com/drugs/DB13719
    Experimental

    Categories: Vasodilators Used in Cardiac Diseases
  2. Drug

    Efloxate

    go.drugbank.com/drugs/DB13333
    Experimental

    Categories: Vasodilators Used in Cardiac Diseases
  3. Drug

    Hematoxylin

    go.drugbank.com/drugs/DB16871
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Bromopyruvate

    go.drugbank.com/drugs/DB17135
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Malachite Green

    go.drugbank.com/drugs/DB03895
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Indole-3-Glycerol Phosphate

    go.drugbank.com/drugs/DB04143
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Carmustine

    go.drugbank.com/drugs/DB00262
    ApprovedInvestigational

    It is used in the treatment of brain tumors and various other malignant neoplasms. … (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985).

    Synonyms: N,N'-Bis(2-chloroethyl)-N-nitrosoureaProducts: Carmustin Waymade 100 mg Pulver und Lösungsmittel für ein Konzentrat zur Herstellung einer Infusionslösung, Carmustin Accordpharma 300 mg Pulver und Lösungsmittel für ein Konzentrat zur Herstellung einer Infusionslösung
  8. Drug

    Etrolizumab

    go.drugbank.com/drugs/DB12189
    Investigational

    [A244574] In the case of [natalizumab], which targets the α4 integrin subunit, this has also resulted in undesirable blockade of lymphocyte CNS trafficking and reported cases of progressive multifocal … Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is typified by a chronic gastrointestinal inflammatory microenvironment, driven in part by the excessive infiltration

  9. Drug

    ETC-1001

    go.drugbank.com/drugs/DB05866
    Experimental

    ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.

  10. Drug

    Alvespimycin

    go.drugbank.com/drugs/DB12442
    Investigational

    Alvespimycin is a derivative of geldanamycin and heat shock protein (HSP) 90 inhibitor. It has been used in trials studying the treatment of solid tumor in various cancer as an antitumor agent. … In comparison to the first HSP90 inhibitor tanespimycin, it exhibits some pharmacologically desirable properties such as reduced metabolic liability, lower plasma protein binding, increased water solubility